A randomised controlled trial of fludarabine/cyclophosphomide combination with or without rituximab in patients with untreated mantle cell lymphoma.

Trial Profile

A randomised controlled trial of fludarabine/cyclophosphomide combination with or without rituximab in patients with untreated mantle cell lymphoma.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Cyclophosphamide (Primary) ; Fludarabine (Primary) ; Fludarabine; Rituximab
  • Indications Mantle-cell lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 May 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
    • 12 Jul 2011 New source identified and integrated (European Clinical Trials Database record).
    • 26 Mar 2011 Planned end date changed from 1 Sep 2010 to 2 Dec 2010 as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top